|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0043227,
umls-concept:C0205263,
umls-concept:C0205265,
umls-concept:C0220825,
umls-concept:C0239307,
umls-concept:C0332293,
umls-concept:C0441771,
umls-concept:C0684249,
umls-concept:C1518904,
umls-concept:C1519810,
umls-concept:C1563350,
umls-concept:C1563351
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-5-6
|
|
pubmed:abstractText |
This study attempted to investigate, in a cohort of patients with clinical stage III initially unresectable non-small cell lung cancer (NSCLC) treated by the same induction chemotherapy regimen, the prognostic value of clinical T and N sub-groupings in order to validate the current International Staging System (ISS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
pubmed-author:BaumöhlJJ,
pubmed-author:BerchierM CMC,
pubmed-author:BureauGG,
pubmed-author:GinerVV,
pubmed-author:KlasterskyJJ,
pubmed-author:LafitteJ JJJ,
pubmed-author:MommenPP,
pubmed-author:NinaneVV,
pubmed-author:PaesmansMM,
pubmed-author:ReclouxPP,
pubmed-author:SculierJ PJP,
pubmed-author:ThiriauxJJ,
pubmed-author:ZachariaeMM,
pubmed-author:van CutsemOO,
pubmed-author:van HouttePP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
201-13
|
|
pubmed:dateRevised |
2009-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:10048473-Adult,
pubmed-meshheading:10048473-Aged,
pubmed-meshheading:10048473-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10048473-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10048473-Cisplatin,
pubmed-meshheading:10048473-Cohort Studies,
pubmed-meshheading:10048473-Female,
pubmed-meshheading:10048473-Humans,
pubmed-meshheading:10048473-Ifosfamide,
pubmed-meshheading:10048473-Karnofsky Performance Status,
pubmed-meshheading:10048473-Lung Neoplasms,
pubmed-meshheading:10048473-Male,
pubmed-meshheading:10048473-Middle Aged,
pubmed-meshheading:10048473-Mitomycin,
pubmed-meshheading:10048473-Neoplasm Staging,
pubmed-meshheading:10048473-Prognosis,
pubmed-meshheading:10048473-Survival Analysis
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
|
|
pubmed:affiliation |
Institut Jules Bordet, Centre des Tumeurs de l'Université Libre Bruxelles, Belgium. 101473.1044@compuserve.com
|
|
pubmed:publicationType |
Journal Article
|
